Native structure of the RhopH complex, a key determinant of malaria parasite nutrient acquisition.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
31 08 2021
Historique:
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 15 12 2021
Statut: ppublish

Résumé

The RhopH complex is implicated in malaria parasites' ability to invade and create new permeability pathways in host erythrocytes, but its mechanisms remain poorly understood. Here, we enrich the endogenous RhopH complex in a native soluble form, comprising RhopH2, CLAG3.1, and RhopH3, directly from parasite cell lysates and determine its atomic structure using cryo-electron microscopy (cryo-EM), mass spectrometry, and the cryoID program. CLAG3.1 is positioned between RhopH2 and RhopH3, which both share substantial binding interfaces with CLAG3.1 but make minimal contacts with each other. The forces stabilizing individual subunits include 13 intramolecular disulfide bonds. Notably, CLAG3.1 residues 1210 to 1223, previously predicted to constitute a transmembrane helix, are embedded within a helical bundle formed by residues 979 to 1289 near the C terminus of CLAG3.1. Buried in the core of the RhopH complex and largely shielded from solvent, insertion of this putative transmembrane helix into the erythrocyte membrane would likely require a large conformational rearrangement. Given the unusually high disulfide content of the complex, it is possible that such a rearrangement could be initiated by the breakage of allosteric disulfide bonds, potentially triggered by interactions at the erythrocyte membrane. This first direct observation of an exported

Identifiants

pubmed: 34446549
pii: 2100514118
doi: 10.1073/pnas.2100514118
pmc: PMC8536402
pii:
doi:

Substances chimiques

Protozoan Proteins 0
rhoptry-associated antigen-2, Plasmodium 145184-78-7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R00 HL133453
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007323
Pays : United States
Organisme : NIH HHS
ID : DP5 OD029613
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI094386
Pays : United States
Organisme : NIH HHS
ID : S10 OD018111
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL133453
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE025567
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR023057
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE028583
Pays : United States
Organisme : NIGMS NIH HHS
ID : U24 GM116792
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM071940
Pays : United States

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Mol Biochem Parasitol. 1988 Jun;29(2-3):251-60
pubmed: 3045543
J Biol Chem. 2019 Feb 22;294(8):2949-2960
pubmed: 30635401
PLoS Pathog. 2020 Feb 18;16(2):e1008363
pubmed: 32069335
mBio. 2018 May 8;9(3):
pubmed: 29739907
Am J Trop Med Hyg. 1984 Nov;33(6):1051-4
pubmed: 6391218
Mol Biochem Parasitol. 2001 Dec;118(2):223-31
pubmed: 11738712
Elife. 2017 Feb 21;6:
pubmed: 28221136
Physiol Rev. 2008 Oct;88(4):1449-90
pubmed: 18923187
Mol Biochem Parasitol. 2003 Mar;127(1):47-57
pubmed: 12615335
J Infect Dis. 2017 Mar 15;215(6):938-945
pubmed: 28419281
Elife. 2017 Mar 02;6:
pubmed: 28252384
Blood. 2004 Dec 15;104(13):4279-86
pubmed: 15319279
Nat Methods. 2014 Jan;11(1):63-5
pubmed: 24213166
Trends Microbiol. 1997 Sep;5(9):363-6
pubmed: 9294893
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Med. 2020 Oct;26(10):1602-1608
pubmed: 32747827
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Annu Rev Biochem. 2015;84:813-41
pubmed: 25621510
Elife. 2017 Mar 02;6:
pubmed: 28252383
J Mol Biol. 2012 Jan 13;415(2):406-18
pubmed: 22100448
Bioinformatics. 2005 Aug 1;21(15):3327-8
pubmed: 15914544
Nature. 2014 Jul 31;511(7511):592-5
pubmed: 25043010
Mol Biochem Parasitol. 2008 Aug;160(2):81-9
pubmed: 18508137
Nucleic Acids Res. 2016 Jan 4;44(D1):D7-19
pubmed: 26615191
Nat Methods. 2020 Jan;17(1):79-85
pubmed: 31768063
Nat Rev Microbiol. 2016 Feb;14(2):77-92
pubmed: 26639780
FEMS Microbiol Rev. 2016 Sep;40(5):701-21
pubmed: 27587718
Nature. 2018 Sep;561(7721):70-75
pubmed: 30150771
Mol Biochem Parasitol. 1985 Mar;14(3):293-303
pubmed: 3887156
Nucleic Acids Res. 2009 Jan;37(Database issue):D539-43
pubmed: 18957442
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Elife. 2021 Jan 04;10:
pubmed: 33393463
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nature. 2000 Aug 31;406(6799):1001-5
pubmed: 10984055
Cell. 2011 May 27;145(5):665-77
pubmed: 21620134
PLoS Pathog. 2021 Feb 3;17(2):e1009293
pubmed: 33534803
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
FASEB J. 2013 Nov;27(11):4619-29
pubmed: 23913858
mBio. 2020 Feb 25;11(1):
pubmed: 32098812
Nat Commun. 2020 Feb 11;11(1):840
pubmed: 32047164
Annu Rev Microbiol. 2013;67:243-69
pubmed: 23808341
FEBS Lett. 2003 Sep 18;552(1):28-34
pubmed: 12972148
Biochemistry. 2006 Jun 20;45(24):7429-33
pubmed: 16768438
Infect Immun. 2015 Jun;83(6):2566-74
pubmed: 25870226
J Cell Biol. 1988 May;106(5):1507-13
pubmed: 2453514
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782998
Redox Biol. 2013 Jul 16;1:373-80
pubmed: 24024174
Mol Biochem Parasitol. 1991 Nov;49(1):99-110
pubmed: 1775161
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Chi-Min Ho (CM)

Department of Microbiology & Immunology, Columbia University, New York, NY 10032; chi-min.ho@columbia.edu Hong.Zhou@UCLA.edu.

Jonathan Jih (J)

California NanoSystems Institute, University of California, Los Angeles, CA 90095.

Mason Lai (M)

California NanoSystems Institute, University of California, Los Angeles, CA 90095.

Xiaorun Li (X)

California NanoSystems Institute, University of California, Los Angeles, CA 90095.

Daniel E Goldberg (DE)

Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO 63110.
Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110.

Josh R Beck (JR)

Department of Biomedical Sciences, Iowa State University, Ames, IA 50011.

Z Hong Zhou (ZH)

California NanoSystems Institute, University of California, Los Angeles, CA 90095; chi-min.ho@columbia.edu Hong.Zhou@UCLA.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH